Ophthalmic Consultants of Long Island
9
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
44%
4 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances
Role: collaborator
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
Role: lead
Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region
Role: lead
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Role: lead
Diurnal Variation in Tear Osmolarity
Role: lead
Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond Laser
Role: lead
Efficacy of Topical Cyclosporin for Ocular Rosacea
Role: lead
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
Role: lead
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Role: lead
All 9 trials loaded